Icure Pharmaceutical Incorporation (175250) — Cash Flow Reinvestment Rate
Icure Pharmaceutical Incorporation (175250) has a Cash Flow Reinvestment Rate of 83.70x as of June 2020, reinvesting ₩16.36 Billion (capex ₩7.44 Billion plus investments ₩8.92 Billion) from operating cash flow of ₩195.44 Million. Check cash flow quality index of Icure Pharmaceutical Incorporation to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Icure Pharmaceutical Incorporation Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Icure Pharmaceutical Incorporation across 1 annual periods. Explore how much of Icure Pharmaceutical Incorporation's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Icure Pharmaceutical Incorporation (2017–2017)
Year-by-year capital reinvestment analysis for Icure Pharmaceutical Incorporation. For live market cap and broader valuation context, see Icure Pharmaceutical Incorporation (175250) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 9.20x | ₩10.30 Billion | ₩1.12 Billion | ₩10.10 Billion | — |